The latest news from the CyberGene team


CyberGene acquires a new patent

CyberGene acquires new patent CyberGene AB has acquired a patent for prenatal diagnostics of the Chromosome 22q11.2 deletion syndrome associated with congenital heart disease (CHD)
ESHG conference booth

ESHG Conference

The ESHG 2022 conference is taking place in Vienna, June 10-13.  We are excited to finally meet the research community, customer and partners face-to-face again.  Contact us at to book a meeting.

Want to get started?

CyberGene supports your lab from start to routine diagnostics